Metraipolis › archive › dc_26547c95ed0b

Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease — Europe PMC PMID:41012446

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012446
DOI
10.3390/pharmaceutics17091107
License (as archived)
solo-consultazione
Archived
2026-11-10T09:11:29.426Z
SHA-256 of the archived text
3942105f8275b8f56673b9fc8da52b1bf5903ede59e4077b5a3096d81544971f
Stable URL of this page
https://metraipolis.com/documento/dc_26547c95ed0b

How to cite

Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease — Europe PMC PMID:41012446 — Europe PMC (en), https://europepmc.org/article/MED/41012446 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_26547c95ed0b (Metraipolis archive dc_26547c95ed0b, sha256 3942105f8275b8f56673b9fc8da52b1bf5903ede59e4077b5a3096d81544971f)
BibTeX
@misc{dc26547c95ed0b,
  title = {Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease — Europe PMC PMID:41012446},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012446},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_26547c95ed0b; sha256 3942105f8275b8f56673b9fc8da52b1bf5903ede59e4077b5a3096d81544971f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012446. Agents can read the archived copy with the MCP tool read_document.